Point-of-Care Oncology: Transforming Early Cancer Diagnostics Through Rapid Testing and Advanced Biomarker Detection Point-of-Care Oncology: The Future of Early Cancer Diagnostics Advances in point-of-care (POC) oncology are reshaping the future…
Why Early Detection Matters: The Foundation of Modern Cancer Diagnostics Why Early Detection Matters Early cancer detection is one of the most significant factors influencing patient care, treatment planning, and…
Rapid Test for Carcinoembryonic Antigen (CEA) | Early Cancer Biomarker Diagnostics | OncoFirm™ Rapid Test for Carcinoembryonic Antigen (CEA) – Colorectal, Breast, Lung, and Pancreatic Cancer Screening Overview:OncoFirm-CEA is a…
OncoFirm-PSA Rapid Test for Prostate-Specific Antigen (PSA) Detection Overview:OncoFirm-PSA is a fast, reliable, and easy-to-use rapid test for the detection of elevated Prostate-Specific Antigen (PSA) levels—an important biomarker in the…